VYNE Therapeutics Inc.

NASDAQ: VYNE · Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM

VYNE Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.58 -0.84 -0.25 -0.72
PEG Ratio
0.05 0.01 0.00 0.01
PS Ratio
284.78 56.45 18.03 3.56
PB Ratio
2.74 0.27 0.28 1.08
P/FCF Ratio
-4.19 -0.94 -0.29 -0.93
P/OCF Ratio
-4.2 -0.94 -0.29 -0.93
OCF/S Ratio
-67.81 -59.77 -61.22 -3.82
Debt / Equity Ratio
0.00 0.00 -0.01 0.01
Quick Ratio
4.35 12.73 4.09 3.04
Current Ratio
4.35 12.73 4.10 3.43
Asset Turnover
0.01 0.00 0.01 0.22
Interest Coverage
n/a n/a n/a -12.13
Return on Equity
-0.76 -0.32 -1.09 -1.51
Return on Assets
-0.6 -0.29 -0.83 -1.09
Return on Invested Capital
-0.84 -0.32 -1.09 -1.37
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.99 1.00 1.00 0.77
Net Profit Margin
-79.51 -67.1 -71.16 -4.97
Pretax Profit Margin
-79.45 -65.74 -71.14 -5
Operating Profit Margin
-87.1 -69 -71.9 -4.61
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-87.09 -69 -71.75 -2.64